Investments

Another month, another purchase. Fortum has been down lately and since it dropped down close to my current average price, I decided to buy additional 60 shares for 16,90 EUR per share. There’s a lot to like in the company itself but it carries also a significant political risk. They are currently sitting on a large pile of cash which should guarantee not only a nice dividend for the years to come but also growth drivers. If that plays out as expected, they should be in a better position in 5+ years scale. Meanwhile I’ll just enjoy the dividends and hope that political risk doesn’t manifest itself in the form of bad growth investments or too high payout ratio.

More info: Fortum investor relations

I really wasn’t planning to add on REIT positions until the interest rate hit would hammer them down but since my second favourite REIT position has been hit so hard lately, I decided to add on Omega Healthcare Investors (OHI). I bought 30 shares for 35,50 USD per share. At the time of writing this it was kind of a DGI community favourite – for example Dividend Mantra explained the quality aspects of the company really well.

This was rather unplanned action but since the monthly cash machine was dropping despite a solid quarterly report, I decided to add on an existing position on Realty Income Corporation (NYSE:O). This time around I averaged up slightly with a purchase of 22 shares for 46,88 USD per  share.

Some information about the latest quarterly report can be found from here: http://seekingalpha.com/article/3120706-an-impressive-quarter-from-the-monthly-dividend-company

 

It’s been a while since the last time I went shopping in NYSE. It was finally possible due to minor changes in EUR/USD exchange rate and USD income from existing positions. As planned I averaged down on Baxter International and bought 15 shares for 68,38 USD per share. Key factor here is the upcoming Baxalta spin-off for which some information can be found from here.

Company profile from http://www.baxter.com/:

Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2014 sales of $16.7 billion and has approximately 65,500 employees.

Plans are meant to be changed. I couldn’t justify converting euros to dollars with the current exchange rate. Otherwise I would have started with Baxter International but in the current situation I’ll wait a while to build up dollar position from dividends received from existing positions. Instead I opened a new position on Telenor by buying 55 shares for 152,70 NOK per share. This is my second Norwegian holding. I’m not super excited about the valuation, this more like a good enough position in the current situation. I might double the position during this month and after that focus on finding something from the euro zone. Right now I’m considering to play the QE scenario by loading up on iShares STOXX Europe Select Dividend 30 UCITS ETF for two to four months.

Summary from http://www.telenor.com/investors/company-facts/:

Telenor Group:
186 million mobile subscriptions
One of the top 500 global companies by market value *
Revenues 2014: NOK 107 billion
Workforce: employees (Q4 2014)
Listed on the Oslo Stock Exchange
Telenor Group has mobile operations in 13 markets and in additionally 14 markets through our ownership in VimpelCom Ltd.

*Financial Times Global 500, 2012

I’ve been looking for an european insurance company for many months now. I was originally looking into companies such as Allianz and Munich Re but settled for a company which has one of the most difficult names in the world to type without any mistakes. On January 21st I bought 70 shares of Gjensidige Forsikring for 123,80 NOK per share. Changing valuation of Norwegian krone played a minor role as well. This is a starter position to which I expect to add on during February.

From https://www.gjensidige.no/group/about-us:

Gjensidige group

We are a leading Nordic general insurance company. We also offer banking-, pension- and savings products in Norway.

Gjensidige has provided insurance services for nearly 200 years.

The Group’s operations are divided into six business areas:
General Insurance Private
General Insurance Commercial
General Insurance Nordic
General Insurance Baltic
Pension and savings
Online retail banking

 

 

Turmoil in Russia presented some unexpected possibilities today. On December 16th I bought 100 shares of Nordea Bank AB for 8,88 EUR per share and 200 shares of TeliaSonera AB for 5,04 EUR per share. Both transactions averaged down on existing positions. Nordea is now on slight overweight and TeliaSonera is a solid full position. Russia is a risk for Nordea but the stock seems to be very attractively valued at these valuations.

On December 15th I bought another 100 shares of Nordea Bank AB for 9.45 EUR per share. This was an existing half position which was now increased to full position. Similar move will be made for TeliaSonera AB at some point (most likely during Q1/2015).

Recent turmoil in commodity stocks resulted extra transactions which I didn’t have planned in my previous shopping list. This might not be a problem after all since I’ve decided to wait for better entry point for Munich Re (or some alternative european insurance company). Meanwhile I hope to increase my position on TeliaSonera AB, restore cash reserves consumed by the extra transactions and start monthly purchases on existing positions to maintain current weightings in the portfolio. On the other hand oil might present some unplanned entry points for companies such as Exxon and Chevron.